American Portfolios Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
GAG
BCM
TWM
CWG
AFWM
PFA
American Portfolios Advisors's BTAL Position: Q3 2022 in Review
American Portfolios Advisors increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 22% in Q3 2022, buying an estimated $1.04M and bringing the position to 286,890 shares worth $5.83M. The position accounts for 0.25% of the portfolio, ranked #76.
American Portfolios Advisors first reported a position in BTAL in Q4 2018 and has held it in 16 quarters since. 63 funds tracked by Wall St. Rank hold BTAL as of Q3 2022.
- American Portfolios Advisors held 286,890 shares of AGF US Market Neutral Anti-Beta Fund worth $5.83M as of Q3 2022.
- American Portfolios Advisors bought 52,438 AGF US Market Neutral Anti-Beta Fund shares in Q3 2022, an estimated $1.04M.
- AGF US Market Neutral Anti-Beta Fund made up 0.25% of American Portfolios Advisors's portfolio in Q3 2022, its #76 holding.
- American Portfolios Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2018 and has held it in 16 quarters since.
- 63 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2022.
Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.